Relative thrombogenicities of several brands of intravascular catheters were measured ill the saphenous and cephalic veins of sheep. Differences in thrombogenicity between brands of up to eleven fold were found. At least one brand contained an ingredient which was locally toxic to sheep and which caused phlebitis in cannulated vessels. The brands tested were made from six types of plastics. It is suggested that differences in mamefacturing technique may be more important than the type of plastic in determining the thrombogenicity of catheters.
Plastic intravascular catheters are frequently inserted into hospitalized patients. In the majority of cases, patients do not appear to have suffered any untoward effects when these are removed. There is evidence in the literature that use of catheters is not without risk. The incidence of phlebitis and of infection in cannulated vessels can be high (Bentley and Lepper 1968 , Collins et al. 1968 , Freedman and King 1972 , Fuchs 1971 , Ahmed and Payne 1976 . At autopsy, intravascular catheters are frequently covered with thrombus (Hoshal et al. 1971 , Norland and Th6ren 1964 , Peters et al. 1973 , Bedford and Wollman 1973 . This thrombus normally remains in the patient when the catheter is withdrawn. Thrombus is an ideal site for microbial multiplication (Henzel and Deweese 1971) and, although a direct connection between the presence of thrombus and of phlebitis and/or infection in a cannulated vessel has yet to be proved, it is likely that these are related. There is also risk of embolism if fragments of thrombus are dislodged (Formanek et al. 1970 , Sketch et al. 1972 , Bames et al. 1973 .
Numerous types and brands of intravascular catheters are available but there is little information on their relative merits. Few papers on the clinical use of intravascular catheters cite the brands used and often there is confusion as to the actual type of plastic of which they are made.
It is disturbing that new types of catheters can be marketed after minimal testing and that in no country is prior testing in blood vessels required. Our previous experiments (Spanos and Hecker 1976) have indicated that thrombogenicity of plastics may be assessed by inserting catheters into veins of sheep and measuring the amount of thrombus present at autopsy several days later. In this paper, we present the results of an experiment in which we have tested a range of intravascular catheters which are used in clinical practice.
MATERIALS AND METHODS
The brands of catheters tested are shown in Table 1 . The majority are representative of those brands of 'long' catheters (25 cm or longer) in use in Sydney hospitals; two are plastic tubings used commonly in animal experiments in Australia. The Argyle Umbilical (TDMAC/heparin) catheters were a batch of Argyle Umbilical catheters treated with tridodecylmethyl ammonium chloride (TDMAC) and then heparin by Grode et al. (1969) of Battelle Laboratories in an attempt to reduce their thrombogenicity. j. F. HECKEl{ ET AL. , <'s, Si:"s and .11al<'l'ials uf :\Iost brands were obtained in pre-sterilized packets and were not re-sterilized before use.
Argyle
Umbilical and Argyll' Umbilical (TDMAC/heparin) catheters were re-sterilized with ethylene oxide while the Dural PVC and the Dural PE tubings were disinfected in 0'1 % benzalkonium chloride for four hours.
Six catheters of each brand were inserted by cut-down under general anaesthesia into each of the saphenous and cephalic veins of mature Merino ewes (Hecker 1974) . To reduce the risk of infection, the ends of the catheters were buried under the skin and no attempts were made to flush them. Each animal was given 300 mg of procaine penicillin and 225 mg of benzathine penicillin by intramuscular injection at the time of cannulation. No more than one catheter of any brand was inserted into a sheep.
Each animal was killed by exsanguination nine days after implantation. Before this, it was given 900 mg of pentobarbitone sodium intravenously as well as 5000 I.U. of heparin to prevent clotting of blood around the catheters. The vessels were carefully dissected and opened and thrombus surrounding the first 25 cm of each catheter was cut into 5 cm lengths and weighed.
:\lass of thrombus on the first 25 cm of catheters was subjected to statistical analysis and significant differences between brands were identified using Duncan's Multiple Range test (Duncan 1955) . Because the variance of mass of thrombus was not independent of the mean mass of thrombus for each brand in each vessel, logarithmic transformation of mass of thrombus was made before statistical analysis (Hecker 1976) .
Catheters were at least 26 cm in length and were selected where possible to be about 1· 5-1 ·6 mm external diameter. Mass of throm bus on larger diameter catheters (Argyle Intramedicut, Sorenson I-V Intrafusor and Pharma-Plast Umbilical (FG 6)) were reduced mathematically before statistical analysis to the equivalent of 1 ·6 mm external diameter, because previous results indicated that thrombus formation was proportional to surface area (Spano, and Hecker 1976) . 
RESt:LTS
We noticed phlebitis with two brands; with seven of the Pharma-Plast Umbilical and one of the Argyle Intramediwt catheters. It occurred for about 10-15 cm from the point of insertion and was characterized by marked thickening of the vessel and surrounding tissues. Sometimes there was pus in the lumen of the vessel. Histological examination showed marked infiltration with neutrophils and degeneration of the vessel wall. Samples were cultured for micro-organisms but on no occasion could any be found. Nor could micro-organisms be seen during histological examination. Short pieces of the Pharma-Plast Umbilical catheters inserted under the skin produced marked inflammatory responses which were not present following subcutaneous implantation of pieces of other brands. These findings suggest that at least the Pharma-Plast Umbilical catheter contains an ingredient which is locally toxic to sheep.
Mean masses of thrombus at different sites in the two vessels are shown in Figure 1 for six of the brands. These brands represent the range of thrombogenicity of the brands tested. There was appreciable thrombus on the first 5 cm of all brands in both vessels. This thrombus was always red and several samples analysed had haemoglobin contents (gig) similar to or slightly greater than those of blood taken at exsanguination. Blood stasis associated with the cutdown procedure may have caused such thrombus (Spanos and Hecker 1976) . Even so, an analysis of variance of mass of thrombus on the 0-5 cm region showed significant differences between brands with a ranking approximately similar to the ranking for the whole 0-25 cm length (see below).
In the 5-20 cm region of the cephalic vein, the amount of thrombus decreased on all but the most thrombogenic catheters and thrombus on all but the most thrombogenic catheters where present was paler than the thrombus in the 0-5 cm region. There was little thrombus present on the 20-25 cm region of catheters in this vessel. At about 20 cm, the cephalic veins of the sheep unite with the jugular veins to form the superior vena cava. This point may be the functional equivalent of the human subclavian vein which is the vessel favoured for long-term catheterization in humans (Dudrick et ill. 1969, Sanderson and Deital 1973) .
There was usually less thrombus after the 11-5 cm region of saphenous vein catheters but after about 15 cm thrombus tended to increase, especially on the more thrombogenic catheters. 
The 15-:t5 cm region in the sheep is in the upper thigh and the vicinity of the hip joint. It is recognized that serious deep vein emboli can originate here in humans (Hume et al. 1973) .
Mass of thrombus on individual catheters and mean mass of thrombus for each brand are given in Table 2 . Differences between vessels and between brands of catheters were significant by analysis of variance (p <0 '001) but the interaction term (vessels X brands) was not significant. Significant differences at the 0 ·05 level as identified by the Multiple Range test are also shown in Table 2 .
Because the statistical analysis was done after logarithmic transformation of the data, it is not possible to state the standard errors of the brand means in arithmetic terms. An approximation can however be obtained from the square root of the residual mean square of the analysis of variance (0 '4087) divided by the degrees of freedom associated with each mean (10). This is in logarithmic units but in arithmetic terms the mean plus one standard error would be [mean X antilog 0·2024] which is 1· 595 times the mean, while the mean minus one standard error would be [mean X antilog -1'7976j which is 0 ·628 times the mean. From these values, the respective means minus one standard error and plus one standard error are 57 and H5 mg for the Extracorporeal Silicone Rubber and 647 and 1644 mg for the Pharma-Plast Umbilical catheters.
DISCUSSION
This project was started because of problems encountered by one of us (G. F.) with catheterization of umbilical arteries of new-born babies suffering from respiratory distress. Treatment involves use of high concentrations of oxygen but the oxygen tension of arterial blood must be controlled to prevent retrolental fibroplasia. Umbilical artery catheterization is frequently used to obtain arterial blood samples. However the use of umbilical artery catheters is associated with complications which include thrombosis of femoral, gastrosplenic and renal arteries (Wigger et al. 1970 , Van Vliet and Gupta 1973 , Neal et al. 1972 ). In one survey, thrombus surrounding umbilical artery catheters was demonstrated by angiography in 18 out of 19 asymptomatic babies (Neal et al. 1972) .
We decided to compare the thrombogenicity of umbilical artery catheters with that of other brands of catheters used in humans and animals. The test that we have developed appears to be suitable for long (>25 cm) catheters but may not be as suitable for short «5 cm) ones which are usually inserted into superficial vessels. Thrombosis in a superficial vessel is less serious than thrombosis in central veins and so we have concentrated our investigations on the longer type of catheter. There were large differences in mean mass of thrombus on the brands tested; those used for umbilical artery catheterization performing badly. Treatment of one brand with TDMAC/heparin did cause a small but non-significant decrease in thrombogenicity. As heparin is leached from TDMAC/heparin surfaces by blood (Grode et al. 1972) , it may be that there would be a significant difference after a shorter period. This would be valuable clinically and is the subject of another investigation. But, although this treatment may reduce thrombogenicity, it would be better to use umbilical artery catheters made from a naturally less thrombogenic material which could then be treated to reduce thrombogenicity further.
The tortuous path of the umbilical artery and the technical difficulties of insertion mean that a relatively flexible plastic material must be used. Silicone Rubber is too flexible unless inserted with a stilette, and most other plastics with the exception of polyvinylchloride are too stiff. Four brands of polyvinylchloride catheters had significantly lower thrombogenicities than the two umbilical artery catheters tested. Of these, the Dural PVC and the Drum-Cartridge Catheter would be suitable materials for an improved umbilical artery catheter but the Sorenson I-V Intrafttsor and Deseret Subclavian would not because, while the first two contain about 25% of plasticiser (as measured by extraction in toluene), the last two contain only about 14% of plasticiser and thus are less flexible.
Our experimental technique may have biased the results against the less thrombogenic catheters. The catheters were inserted by cutdown which would have stopped flow of blood around the catheter for 2-3 cm. Most of the thrombus on the less thrombogenic catheters was associated with the first few centimetres (Figure 1) . The usual method for insertion of most brands into patients is either over a removable needle (e.g. E-Z Cath) or through a needle or cannula inserted into the vessel (e.g.
Argyle Intramedicut, Bard I-Cath). These techniques would not normally stop blood flow. One of our reasons for insertion of all by cutdown is that umbilical artery catheterization is similar to insertion by cut-down in that the catheter is surrounded by stagnant blood for a short distance.
There is also a need for a better catheter for long-term central venous use. ~Iost of the brands used for central venous catheterization are relatively inflexible (e.g. Bard I-Cath, Deseret Subclavian and Sorenson I-V Intrajusor). Inflexibility means that the catheter will press against the vessel wall at bends. We believe from observations made while dissecting vessels that this may be one of the factors that determine thrombus formation. The tip of an inflexible catheter may also lie against the wall where movement can cause damage and so induce thrombus. The Extracorporeal Silicone Rubber catheter is flexible and would float in the blood stream. This catheter had the lowest thrombogenicity but it unfortunately has only a small lumen (about 0·5 mm) and this small lumen would restrict its use.
In normal use, fluids are regularly passed through the lumens of catheters. 'Ne believe that non-flushing and non use of these catheters did not affect the results as we measured thrombus that formed on the outside surface of the catheters. Flushing would only dislodge thrombus from the catheter tip and anticoagulants introduced could also only affect thrombus formation at the tip.
The actual type of plastic used in the manufacture of some of the catheters was not ~tated and so we used various tests for identification of type of plastic. These tests included differential thermal absorption and infra-red spectroscopy (for PVCjPVA copolymers) and the ability of organic solvents such as toluene to extract appreciable amounts of plasticiser from polyvinylchloride. The catheters tested were made from six types of plastics (Table 1) .
We believe that it is misleading to identify particular types of plastics as being more or less thrombogenic than others. The least thrombogenic brand tested was the Extracorporeal Silicone Rubber catheter. 'Ve have done some tests on Pudenz valve tubing used for ventriculoatrial shunts to relieve hydrocephalus. This is also made from silicone rubber but unlike the Extracorporeal catheter it appears to be very thrombogenic. There were also marked differences in thrombogenicity between brands made from another type of plastic, polyvinylchloride (Table 2 ). These differences suggest that differences in manufacturing technique may be more critical in determining thrombogenicity than the actual type of plastic used. We hope to identify some of the factors which cause differences in thrombogenicity in subsequent experiments.
